Professional Documents
Culture Documents
HEALTH ORGANIZATION
Member profile
The International Pharmaceutical Federation (FIP) is the global federation of national associations of
pharmacists and pharmaceutical scientists, encompassing three million pharmacists and scientists
through its 127 Member Organisations.
FIP has been in official relations with the World Health Organization (WHO) since its inception in
1948 and has official UN ECOSOC status – affiliations that assist in the Federation’s Mission to
improve global health by advancing pharmacy practice and science to enable better discovery,
development, access to and safe use of appropriate, cost-effective, quality medicines worldwide.
Main activities
FIP is active across all areas of pharmacy practice, pharmaceutical science and education, primarily
through the work of member associations and dedicated volunteers. FIP initiates and implements
numerous projects and programmes to improve the responsible use of medicines that are making a
significant impact within global pharmacy practice, pharmaceutical sciences, education and
community health.
Without access to and responsible use of quality medicines, health systems lose their ability to meet
health care needs. The pharmacy workforce crisis threatens the ability of many countries to deliver
pharmaceutical health services. The International Pharmaceutical Federation (FIP) has sought to
address this crisis by gathering global data on the pharmacy workforce and developing evidence-
based background papers to serve as advocacy tools at country, regional and global levels, as well as,
by building the capacity of national association leaders and educators to work with governments and
stakeholders towards developing sound pharmaceutical policies and pharmaceutical human
resources in their countries.
Also building on the success of the Global Pharmacy Education Taskforce, supported by the World
Health Organization (WHO) and United Nations Educational, Scientific and Cultural Organization
(UNESCO), the FIP Education Initiatives (FIPEd) was launched in March 2011. FIPEd has a Mission to
bring together organisations, stakeholders and leaders who are working to improve health through
advancing pharmacy and pharmaceutical sciences education. FIPEd is stimulating transformational
change in pharmacy and pharmaceutical science education to advance and develop our diverse
profession towards meeting present and future health care needs around the world.
FIP's Higlights:
The 2012 FIP Global Pharmacy Workforce Report is the most comprehensive report on the subject,
including an analysis of the global pharmacy workforce situation and description of country
experiences and solutions. Based on data from 90 countries and territories, the report paints a
mixed picture of progress, diversity and capacity.
The most up-to-date and extensive listing of Pharmacy and Pharmaceutical Sciences Schools,
Faculties and Departments is managed by FIP. This listing is openly available online at
http://aim.fip.org/world-list-of-pharmacy-schools/ and included the contact details of over 2000
schools.
FIP: I am a Pharmacist
iamapharmacist
The I am a Pharmacist project was developed to create more pride, solidarity and awareness of
the pharmacy profession on a global level in a unique and current social medium. The website
includes I am a Pharmacist videos from pharmacists and pharmaceutical scientists making a
difference all around the world.
Community pharmacy
Community pharmacists are the health professionals most accessible to the public. They supply
medicines in accordance with a prescription or, when legally permitted, sell them without a
prescription. In addition to ensuring an accurate supply of appropriate products, their professional
activities also cover counselling of patients at the time of dispensing of prescription and non-
prescription drugs, drug information to health professionals, patients and the general public, and
participation in health-promotion programmes. They maintain links with other health professionals
in primary health care.
Today, an increasingly wide range of new and analogous products are used in medicine, including
high-technology biological products and radio-pharmaceuticals. There is also the heterogeneous
group of medical devices, which includes some products analogous to medicines, some of which
demand special knowledge with regard to their uses and risks (e.g., dressings, wound management
products, etc.).
Pharmacists have progressively undertaken the additional task of ensuring the quality of the
products they supply.
Processing of prescriptions
The pharmacist verifies the legality, safety and appropriateness of the prescription order, checks the
patient medication record before dispensing the prescription (when such records are kept in the
pharmacy), ensures that the quantities of medication are dispensed accurately, and decides whether
the medication should be handed to the patient, with appropriate counselling, by a pharmacist. In
many countries, the community pharmacist is in a unique position to be fully aware of the patient’s
past and current drug history and, consequently, can provide essential advice to the prescriber.
The pharmacist seeks to collect and integrate information about the patient’s drug history, clarify
the patient’s understanding of the intended dosage regimen and method of administration, and
advises the patient of drug-related precautions, and in some countries, monitors and evaluates the
therapeutic response.
The pharmacist can participate in arrangements for monitoring the utilization of drugs, such as
practice research projects, and schemes to analyse prescriptions for the monitoring of adverse drug
reactions.
Pharmacists everywhere continue to prepare medicines in the pharmacy. This enables them to adapt
the formulation of a medicine to the needs of an individual patient. New developments in drugs and
delivery systems may well extend the need for individually adapted medicines and thus increase the
pharmacist’s need to continue with pharmacy formulation. In some countries, developed and
developing, pharmacists engage in the small-scale manufacture of medicines, which must accord
with good manufacturing and distribution practice guidelines.
The pharmacist receives requests from members of the public for advice on a variety of symptoms
and, when indicated, refers the inquiries to a medical practitioner. If the symptoms relate to a self-
limiting minor ailment, the pharmacist can supply a non-prescription medicine, with advice to
consult a medical practitioner if the symptoms persist for more than a few days. Alternatively, the
pharmacist may give advice without supplying medicine.
The pharmacist can compile and maintain information on all medicines, and particularly on newly
introduced medicines, provide this information as necessary to other health care professionals and
to patients, and use it in promoting the rational use of drugs, by providing advice and explanations
to physicians and to members of the public.
Health promotion
The pharmacist can take part in health promotion campaigns, locally and nationally, on a wide range
of health-related topics, and particularly on drug-related topics (e.g., rational use of drugs, alcohol
abuse, tobacco use, discouragement of drug use during pregnancy, organic solvent abuse, poison
prevention) or topics concerned with other health problems (diarrhoeal diseases, tuberculosis,
leprosy, HIV-infection/AIDS) and family planning. They may also take part in the education of local
community groups in health promotion, and in campaigns on disease prevention, such as the
Expanded Programme on Immunization, and malaria and blindness programmes.
Domiciliary services
Pharmacy Organizations
http://www.amcp.org/home
http://www.aapspharmaceutica.com/
AACP strives to be a source of creative energy for members as they seek excellence in accomplishing
their missions of teaching, scholarship, and service. As faculty of colleges and schools of pharmacy
analyze changes in (1) the profession of pharmacy and the delivery of health care; (2) societal
demands on higher education; and (3) support for research in the sciences fundamental to
pharmacy, AACP will be an important catalyst for creative ideas and practical strategies for
advancing pharmaceutical education to better meet the requirements of students, employers, and
society.
http://www.aacp.org
The College is the leading resource for improvement in cardiopulmonary health and critical care
worldwide. In addition, the College’s mission is to promote the prevention and treatment of diseases
of the chest through leadership, education, research, and communication.
http://www.chestnet.org/
The American College of Clinical Pharmacy (ACCP) exists to advance human health and quality of life
by helping pharmacists expand the frontiers of their practice and research. ACCP will pursue its core
purpose by:
Providing leadership, education, advocacy, and other resources that enable pharmacists to
achieve excellence in clinical practice and research;
http://www.accp.com
The American Heart Association is a national voluntary health agency whose mission is: "Building
healthier lives, free of cardiovascular diseases and stroke."
The Association's impact goal is to reduce coronary heart disease, stroke, and risk by 25% by 2010.
Progress toward the goal will be measured according to these indicators:
Reduce the death rate from coronary heart disease and stroke by 25%.
Reduce the prevalence of smoking, high blood cholesterol, and physical inactivity by 25%.
http://www.americanheart.org
Founded in 1852, the American Pharmacists Association (APhA) was the first national professional
society of pharmacists. Originally, APhA was called the American Pharmaceutical Association. APhA
is the largest association of pharmacists in the United States, with a membership of more than
60,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy
technicians, and others interested in advancing the profession.
http://www.pharmacist.com
The American Society of Consultant Pharmacists (ASCP) is the international professional association
that provides leadership, education, advocacy, and resources to advance the practice of consultant
and senior care pharmacy. ASCP envisions a future in which:
The senior population realizes improved quality of care and quality of life through the
provision of pharmaceutical care.
Consultant and senior care pharmacists are essential professionals in health care systems
and are recognized and valued for their care of patients.
ASCP is the acknowledged leader in consultant and senior care pharmacy practice.
http://www.ascp.com/
http://www.ashp.org/
The Task Force on Specialties in Pharmacy organized the Board of Pharmacy Specialties (BPS) in 1976
as an independent certification agency of APhA.
BPS has four primary responsibilities:
Serves as the information resource and coordinating agency for pharmacy specialties.
The overriding concern of BPS is to ensure that the public receives the level of pharmacy services
that will improve a patient’s quality of life. Currently, BPS recognizes five specialty practice areas:
Nuclear Pharmacy, Nutrition Support Pharmacy, Oncology Pharmacy, Pharmacotherapy, and
Psychiatric Pharmacy.
http://www.bpsweb.org/Home.html
The mission of the College of Psychiatric and Neurologic Pharmacists (CPNP) is to promote
excellence in pharmacy practice, education, and research to optimize the treatment outcomes of
individuals affected by psychiatric and neurologic disorders by:
Promoting and supporting certification within the psychiatry and neurology specialty
http://cpnp.org/
Provide educational activities through its scientific conferences, Web site, newsletter,
written communications (e.g., educational monographs, treatment standards, guidelines),
and clinical training programs (residencies, fellowships, and traineeships) for oncology
pharmacists and other health care professionals who care for patients with cancer. Through
these educational initiatives, HOPA members will be able to incorporate contemporary and
best practices into cancer care, maximizing patient benefits while minimizing suffering and
costs due to possible medication errors and adverse effects.
https://www.hoparx.org
The goal of the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) is to
continuously improve the safety and quality of care provided to the public through the provision of
health care accreditation and related services that support performance improvement in health care
organizations.
http://www.jointcommission.org/
Founded in 1933, the National Association of Chain Drug Stores (NACDS) works to provide the chain
drug industry a unified voice necessary for growth and success. NACDS is still dedicated to its original
vision: representing the nation's leading retail chain pharmacies and suppliers.
http://www.nacds.org/
The National Community Pharmacists Association (NCPA) represents the pharmacist owners,
managers, and employees from more than 23,000 independent community pharmacies across the
United States. The nation's independent pharmacies, independent pharmacy franchises, and
independent chains dispense nearly half of the nation's retail prescription medicines.
http://www.ncpanet.org/
http://www.ppag.org/
The mission of the Society of Critical Care Medicine (SCCM) is to secure the highest-quality care for
all critically ill and injured patients. SCCM envisions a world in which all critically ill and injured
persons receive care from integrated teams of dedicated experts directed by trained and present
intensivist physicians.
Multiprofessional teams use knowledge, technology, and compassion to provide timely, safe,
effective, and efficient patient-centered care.
http://www.sccm.org
Society of Infectious Diseases Pharmacists (SIDP):
The Society of Infectious Diseases Pharmacists (SIDP) is a dynamic association of health professionals
dedicated to promoting the appropriate use of antimicrobials. SIDP provides education, advocacy,
and leadership in all aspects of the treatment of infectious diseases. SIDP is composed of
pharmacists and other health care professionals involved in patient care, research, teaching, drug
development, and governmental regulation who are concerned with all facets of antimicrobial use
and committed to excellence in infectious diseases pharmacotherapy.
http://www.sidp.org/